PT99340A - Processo para a preparacao de composicoes farmaceuticas anticoncepcionais contendo um estrogenio em mistura com 16-metileno-17 alfa-acetoxi-19-nor-4-pregneno-3,20-diona para administracao por via transdermica e dispositivo para a realizacao da administracao - Google Patents
Processo para a preparacao de composicoes farmaceuticas anticoncepcionais contendo um estrogenio em mistura com 16-metileno-17 alfa-acetoxi-19-nor-4-pregneno-3,20-diona para administracao por via transdermica e dispositivo para a realizacao da administracaoInfo
- Publication number
- PT99340A PT99340A PT99340A PT9934091A PT99340A PT 99340 A PT99340 A PT 99340A PT 99340 A PT99340 A PT 99340A PT 9934091 A PT9934091 A PT 9934091A PT 99340 A PT99340 A PT 99340A
- Authority
- PT
- Portugal
- Prior art keywords
- administration
- estrogen
- anticonceptional
- transdermic
- diona
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
- Semiconductor Lasers (AREA)
- Vending Machines For Individual Products (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/605,726 US5122382A (en) | 1990-10-29 | 1990-10-29 | Transdermal contraceptive formulations, methods and devices |
Publications (2)
Publication Number | Publication Date |
---|---|
PT99340A true PT99340A (pt) | 1992-09-30 |
PT99340B PT99340B (pt) | 1999-02-26 |
Family
ID=24424948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT99340A PT99340B (pt) | 1990-10-29 | 1991-10-25 | Processo para a preparacao de composicoes farmaceuticas anticoncepcionais contendo um estrogenio em mistura com 16-metileno-17 alfa-acetoxi-19-nor-4-pregneno-3,20-diona para administracao por via transdermica e dispositivo para a realizacao da administracao |
Country Status (16)
Country | Link |
---|---|
US (1) | US5122382A (pt) |
EP (1) | EP0577602B1 (pt) |
JP (1) | JP2975684B2 (pt) |
AT (1) | ATE171069T1 (pt) |
AU (1) | AU9041991A (pt) |
CA (1) | CA2088778C (pt) |
DE (1) | DE69130232T2 (pt) |
DK (1) | DK0577602T3 (pt) |
ES (1) | ES2123547T3 (pt) |
IE (1) | IE913741A1 (pt) |
MX (1) | MX9101784A (pt) |
NO (1) | NO303527B1 (pt) |
NZ (1) | NZ240361A (pt) |
PT (1) | PT99340B (pt) |
WO (1) | WO1992007589A1 (pt) |
ZA (1) | ZA918531B (pt) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5560922A (en) * | 1986-05-30 | 1996-10-01 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process |
US5256421A (en) * | 1987-09-24 | 1993-10-26 | Jencap Research Ltd. | Hormone preparation and method |
US5276022A (en) * | 1987-09-24 | 1994-01-04 | Jencap Research Ltd. | Hormone preparation and method |
DK0754456T3 (da) * | 1990-06-01 | 2002-11-11 | Population Council Inc | Forberedelse af sammensætninger der omfatter ST1435 til topisk anvendelse |
US5320850A (en) * | 1990-10-29 | 1994-06-14 | Alza Corporation | Transdermal delivery of the gestogen ST-1435 and devices therefor |
JP2960832B2 (ja) * | 1992-05-08 | 1999-10-12 | ペルマテック テクノロジー アクチェンゲゼルシャフト | エストラジオールの投与システム |
US5900250A (en) * | 1992-05-13 | 1999-05-04 | Alza Corporation | Monoglyceride/lactate ester permeation enhancer for oxybutnin |
MX9303557A (es) * | 1992-08-06 | 1994-03-31 | Beta Pharm Co | Metodo para la administracion de un antiandrogeno, en particular, espironolactona, a traves de la piel. |
CA2114968A1 (en) * | 1993-02-25 | 1994-08-26 | John Wille | Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity |
CA2165802A1 (en) * | 1993-09-29 | 1995-04-06 | Eun Soo Lee | Monoglyceride/lactate ester permeation enhancer for oxybutynin |
DE4400770C1 (de) * | 1994-01-13 | 1995-02-02 | Lohmann Therapie Syst Lts | Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung |
DE19513662A1 (de) * | 1995-04-08 | 1996-10-10 | Schering Ag | Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption |
US5882676A (en) * | 1995-05-26 | 1999-03-16 | Alza Corporation | Skin permeation enhancer compositions using acyl lactylates |
US5785991A (en) * | 1995-06-07 | 1998-07-28 | Alza Corporation | Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate |
AU726283B2 (en) * | 1995-06-28 | 2000-11-02 | Schering Aktiengesellschaft | Pharmaceutical combined preparations, kit and method for hormonal contraception |
DE19525017A1 (de) * | 1995-06-28 | 1997-01-02 | Schering Ag | Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption |
FR2739032B1 (fr) * | 1995-09-27 | 1997-11-21 | Lhd Lab Hygiene Dietetique | Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base d'eva, procede de preparation et utilisation en therapeutique |
US5730721A (en) * | 1996-01-25 | 1998-03-24 | Vesture Corporation | Medical applicator and method |
US6512010B1 (en) * | 1996-07-15 | 2003-01-28 | Alza Corporation | Formulations for the administration of fluoxetine |
US6203817B1 (en) | 1997-02-19 | 2001-03-20 | Alza Corporation | Reduction of skin reactions caused by transdermal drug delivery |
WO1999032153A1 (en) * | 1997-12-22 | 1999-07-01 | Alza Corporation | Monoglyceride and ethyl palmitate permeation enhancer compositions |
US6699497B1 (en) * | 1998-07-24 | 2004-03-02 | Alza Corporation | Formulations for the transdermal administration of fenoldopam |
BR9916214A (pt) * | 1998-12-18 | 2001-09-11 | Alza Corp | Dispositivos de distribuição de nicotina transdérmicos transparentes |
US7384650B2 (en) | 1999-11-24 | 2008-06-10 | Agile Therapeutics, Inc. | Skin permeation enhancement composition for transdermal hormone delivery system |
AU2003288699A1 (en) * | 2002-12-30 | 2004-07-22 | Given Imaging Ltd. | Method for in vivo sensing |
US20040258742A1 (en) * | 2003-04-11 | 2004-12-23 | Van Osdol William Woodson | Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines |
US20070259930A1 (en) * | 2006-04-10 | 2007-11-08 | Knopp Neurosciences, Inc. | Compositions and methods of using r(+) pramipexole |
US8518926B2 (en) * | 2006-04-10 | 2013-08-27 | Knopp Neurosciences, Inc. | Compositions and methods of using (R)-pramipexole |
CA2652251A1 (en) * | 2006-05-16 | 2007-11-29 | Knopp Neurosciences, Inc. | Compositions of r(+) and s(-) pramipexole and methods for using the same |
US8524695B2 (en) * | 2006-12-14 | 2013-09-03 | Knopp Neurosciences, Inc. | Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same |
WO2008113056A2 (en) * | 2007-03-14 | 2008-09-18 | Knopp Neurosciences, Inc. | Synthesis of chirally purified substituted benzothiazole diamines |
US20100292660A1 (en) * | 2007-07-10 | 2010-11-18 | Agis Kydonieus | Dermal delivery device with ultrasonic weld |
BRPI0814697B8 (pt) | 2007-07-10 | 2021-05-25 | Agile Therapeutics Inc | dispositivo de liberação de fármacos |
US20110190356A1 (en) * | 2008-08-19 | 2011-08-04 | Knopp Neurosciences Inc. | Compositions and Methods of Using (R)- Pramipexole |
CN102802418A (zh) * | 2009-06-19 | 2012-11-28 | 诺普神经科学股份有限公司 | 用于治疗肌萎缩性侧索硬化的组合物和方法 |
ES2641613T3 (es) * | 2009-12-17 | 2017-11-10 | The Population Council, Inc. | Gel transdérmico de Nestorone®/Estradiol |
EP3513787A1 (en) | 2011-01-10 | 2019-07-24 | Invion, Inc | Use of beta-adrenergic inverse agonists for smoking cessation |
WO2013096816A1 (en) | 2011-12-22 | 2013-06-27 | Biogen Idec Ma Inc. | Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds |
WO2013177570A1 (en) | 2012-05-25 | 2013-11-28 | Terapio Corporation | Methods of preventing or treating disease of the central nervous system using rlip76 |
US9662313B2 (en) | 2013-02-28 | 2017-05-30 | Knopp Biosciences Llc | Compositions and methods for treating amyotrophic lateral sclerosis in responders |
CN105764507B (zh) | 2013-07-12 | 2019-07-19 | 诺普生物科学有限责任公司 | 治疗升高的嗜酸性粒细胞和/或嗜碱性粒细胞的水平 |
US9468630B2 (en) | 2013-07-12 | 2016-10-18 | Knopp Biosciences Llc | Compositions and methods for treating conditions related to increased eosinophils |
ES2871556T3 (es) | 2013-08-13 | 2021-10-29 | Knopp Biosciences Llc | Composiciones y métodos para el tratamiento de la urticaria crónica |
ES2813674T3 (es) | 2013-08-13 | 2021-03-24 | Knopp Biosciences Llc | Composiciones y métodos para el tratamiento de trastornos de células plasmáticas y trastornos prolinfocíticos de células b |
EP3046544A4 (en) | 2013-09-17 | 2017-03-22 | Terapio Corporation | Methods of preventing or treating mucositis using rlip76 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3800038A (en) * | 1972-04-21 | 1974-03-26 | Biolog Concepts Inc | Uterine administraton of eutectic solid solutions of steroid hormones in a steroidal lipid carrier |
US4816258A (en) * | 1987-02-26 | 1989-03-28 | Alza Corporation | Transdermal contraceptive formulations |
CH674618A5 (pt) * | 1987-04-02 | 1990-06-29 | Ciba Geigy Ag |
-
1990
- 1990-10-29 US US07/605,726 patent/US5122382A/en not_active Expired - Lifetime
-
1991
- 1991-10-25 IE IE374191A patent/IE913741A1/en not_active IP Right Cessation
- 1991-10-25 MX MX9101784A patent/MX9101784A/es unknown
- 1991-10-25 ZA ZA918531A patent/ZA918531B/xx unknown
- 1991-10-25 AU AU90419/91A patent/AU9041991A/en not_active Abandoned
- 1991-10-25 AT AT92900228T patent/ATE171069T1/de not_active IP Right Cessation
- 1991-10-25 EP EP92900228A patent/EP0577602B1/en not_active Expired - Lifetime
- 1991-10-25 DE DE69130232T patent/DE69130232T2/de not_active Expired - Lifetime
- 1991-10-25 CA CA002088778A patent/CA2088778C/en not_active Expired - Lifetime
- 1991-10-25 JP JP4500802A patent/JP2975684B2/ja not_active Expired - Lifetime
- 1991-10-25 WO PCT/US1991/007877 patent/WO1992007589A1/en active IP Right Grant
- 1991-10-25 NZ NZ240361A patent/NZ240361A/en not_active IP Right Cessation
- 1991-10-25 PT PT99340A patent/PT99340B/pt not_active IP Right Cessation
- 1991-10-25 DK DK92900228T patent/DK0577602T3/da active
- 1991-10-25 ES ES92900228T patent/ES2123547T3/es not_active Expired - Lifetime
-
1993
- 1993-03-31 NO NO931209A patent/NO303527B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2088778C (en) | 2001-08-14 |
US5122382A (en) | 1992-06-16 |
ATE171069T1 (de) | 1998-10-15 |
WO1992007589A1 (en) | 1992-05-14 |
CA2088778A1 (en) | 1992-04-30 |
IE913741A1 (en) | 1992-05-22 |
NO303527B1 (no) | 1998-07-27 |
AU9041991A (en) | 1992-05-26 |
JPH06502429A (ja) | 1994-03-17 |
NO931209D0 (no) | 1993-03-31 |
EP0577602A1 (en) | 1994-01-12 |
DK0577602T3 (da) | 1999-06-14 |
ZA918531B (en) | 1992-08-26 |
MX9101784A (es) | 1992-06-05 |
ES2123547T3 (es) | 1999-01-16 |
JP2975684B2 (ja) | 1999-11-10 |
EP0577602B1 (en) | 1998-09-16 |
NO931209L (no) | 1993-04-26 |
PT99340B (pt) | 1999-02-26 |
NZ240361A (en) | 1995-07-26 |
DE69130232D1 (de) | 1998-10-22 |
DE69130232T2 (de) | 1999-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT99340A (pt) | Processo para a preparacao de composicoes farmaceuticas anticoncepcionais contendo um estrogenio em mistura com 16-metileno-17 alfa-acetoxi-19-nor-4-pregneno-3,20-diona para administracao por via transdermica e dispositivo para a realizacao da administracao | |
PT99513A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo profarmacos de morfina para administracao topica por via transdermica | |
ES2055845T3 (es) | Composicion farmaceutica para el tratamiento de la osteoporosis. | |
BR9812134A (pt) | Composição farmacêutica para tratamento de dismenorréia e parto prematuro | |
DE58906926D1 (de) | Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung. | |
MX9200324A (es) | Nuevos esteroides, procedimiento para su preparacinuevos esteroides, procedimiento para su preparacion y composicion farmaceutica que los contiene. on y composicion farmaceutica que los contiene. | |
ES2018478B3 (es) | Un sistema para preparar una composicion desensibilizante dental. | |
ES2107832T3 (es) | Una composicion farmaceutica para la administracion intranasal de hidroxocobalamina. | |
PT94139A (pt) | Processo de preparacao de composicoes farmaceuticas a base de imipramina | |
BR9610679A (pt) | Antígenos de leishmania para uso na terapia e disgnose da leishmaniose | |
ES2190205T3 (es) | Combinacion para el tratamiento de la dependencia del alcohol que contiene un antagonista opioide y un modulador del complejo receptor de nmda. | |
ECSP930933A (es) | Composicion farmaceutica y procedimiento para prepararla | |
ATE433339T1 (de) | Parasympathikomimetikum und parasympathikolytikum enthaltendes tts | |
MX9207605A (es) | Composicion farmaceutica que contiene glucosidos de antraciclina unidos a un derivado polimerico y metodo para preparar la misma. | |
PL315127A1 (en) | Deuterised biologically active substances for percutaneous administration | |
ES2059312T3 (es) | Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion. | |
KR880700814A (ko) | 아미노글리코사이드 스테로이드, 이의 제조방법, 이의 용도 및 이를 함유하는 약제학적 조성물 | |
AR002017A1 (es) | Derivados de fenil-4-tiazoles substituidos, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y derivados defenil-4-tiazoles substituidos empleados en dicho procedimiento. | |
DE69104083D1 (de) | Neue Antiulcus-Substanz. | |
KR880700815A (ko) | 아미노글리코사이드 스테로이드, 그의 제조방법, 그의 용도 및 이를 함유하는 약제학적 조성물 | |
DE3682431D1 (de) | Pharmazeutische zusammensetzung zur behandlung nichtlymphatischer leukaemie und verfahren zur herstellung derselben und ihrer komponenten. | |
HRP20000781B1 (en) | Effervescent preparations | |
DE69624563D1 (de) | Pharmazeutische zusammensetzung hergestellt durch zugabe eines geschmackstoff an einer wirkstoff | |
ES2134503T3 (es) | Envase para parches de principio activo, sin riesgo para los niños. | |
SE8503447D0 (sv) | Farmaceutiska och kosmetiska kompositioner, innehallande dihydroxi-1,8-fenyl-10-antron-9 som verksam bestandsdel, samt sett att framstella den verksamma foreningen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB1A | Laying open of patent application |
Effective date: 19920427 |
|
FG3A | Patent granted, date of granting |
Effective date: 19981124 |
|
MM4A | Annulment/lapse due to non-payment of fees, searched and examined patent |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20120524 |